Filing Details

Accession Number:
0001179110-17-012310
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-14 20:21:16
Reporting Period:
2017-09-12
Accepted Time:
2017-09-14 20:21:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Plc NBRV () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232258 Ltd. (Cayman) Investments Healthcare Hbm Governors Square, Suite #4-212-2
23 Lime Tree Bay Ave., West Bay
Grand Cayman E9 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2017-09-12 10,458 $8.63 2,360,278 No 4 S Direct
Ordinary Shares Disposition 2017-09-13 22,721 $8.54 2,337,557 No 4 S Direct
Ordinary Shares Disposition 2017-09-14 3,429 $8.52 2,334,128 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $8.53 to $8.825. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price.
  2. The balance was adjusted by one (1) share to account for a mathematical error in a prior filing.
  3. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $8.5 to $8.685. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price
  4. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $8.5 to $8.6386. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price.